5 THINGS YOU MUST KNOW ABOUT IGM BIOSCIENCES! $IGMS
IGM Biosciences, Inc. (NASDAQ: IGMS) announced an exclusive worldwide collaboration agreement with Sanofi for developing and commercializing IgM antibody agonists against six initial targets, three in oncology and three in immunology/inflammation.
[url=https://www.aviseanalytics.com/5-things-you-must-know-about-igm-biosciences/ ]Here are 5 things you must know about the Company![/url]
https://www.aviseanalytics.com/5-things-you-must-know-about-igm-biosciences/